candesartan has been researched along with 3,4-dihydroxyphenylacetic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mertens, B; Michotte, Y; Sarre, S; Vanderheyden, P | 1 |
1 other study(ies) available for candesartan and 3,4-dihydroxyphenylacetic acid
| Article | Year |
|---|---|
Direct angiotensin II type 2 receptor stimulation decreases dopamine synthesis in the rat striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Benzimidazoles; Biphenyl Compounds; Catheterization; Central Nervous System Agents; Corpus Striatum; Dopa Decarboxylase; Dopamine; Extracellular Space; Hydrazines; Imidazoles; Levodopa; Male; Microdialysis; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles; Tyrosine 3-Monooxygenase | 2010 |